ABCC1 and chronic obstructive pulmonary disease: However, AITC has been evaluated as a possible treatment for respiratory diseases like chronic obstructive pulmonary disease (COPD) and asthma, through its effects on the inflammatory response and increased expression of multidrug resistance-associated protein 1 (MRP1) in the lungs [56,57,58].